title: Successful treatment of intractable scleromyxedema with cyclosporin A.
authors.forename: S
authors.initials: S
authors.lastname: Saigoh
authors.forename: A
authors.initials: A
authors.lastname: Tashiro
authors.forename: S
authors.initials: S
authors.lastname: Fujita
authors.forename: M
authors.initials: M
authors.lastname: Matsui
authors.forename: S
authors.initials: S
authors.lastname: Shibata
authors.forename: H
authors.initials: H
authors.lastname: Takeshita
authors.forename: H
authors.initials: H
authors.lastname: Duan
authors.forename: Y
authors.initials: Y
authors.lastname: Moroi
authors.forename: K
authors.initials: K
authors.lastname: Urabe
authors.forename: T
authors.initials: T
authors.lastname: Koga
authors.forename: M
authors.initials: M
authors.lastname: Furue
mesh_terms: D016572:Cyclosporine / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009230:Myxedema / Q000188:drug therapy / Q000276:immunology / Q000628:therapy; D012595:Scleroderma, Systemic / Q000188:drug therapy / Q000276:immunology / Q000628:therapy; D012871:Skin Diseases / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D003879:Dermatologic Agents; D016572:Cyclosporine